BCG vaccination coverage data by age group

Data by age group

Under 24 months

Confirmed and reported BCG vaccination coverage in the Île-de-France region (departments 75, 92, 93, 94), estimated for children aged 3 months and older, VACSIRS study, 2010 (source: Inserm U707, InVS)

BCG vaccination coverage

n analyzed

Estimated CV

95% CI

p

Before versus after the discontinuation of multiple injections (01/01/06)

Confirmed

Before 01/01/06

164

95.3%

82.5 – 98.8

After 01/01/06

270

82.7%

70.9 – 90.4

0.07

Reported

Before 01/01/06

229

95.7%

86.2 – 98.8

After 01/01/06

401

85.2%

75.9 – 91.3

0.07

Whether or not from a country with high tuberculosis endemicity among children born after the withdrawal of the multiple-site blood draw (01/01/06)

Confirmed

From a country with high endemicity

89

97.3%

88.4 – 99.4

Not from a country with high endemicity

181

78.6%

64.5 – 88.1

< 0.001

Reported

From a country with high endemicity

143

98.4%

94.4 – 99.6

Not from a country with high endemicity

258

79.7%

68.3 – 87.8

< 0.001

  • Guthmann JP, Chauvin P, Le Strat Y, Soler M, Fonteneau L, Lévy-Bruhl D. Socioeconomic determinants of BCG and pneumococcal vaccinations among children in the Paris region. Results of the VACSIRS survey, 2010. Saint-Maurice: Institute for Public Health Surveillance, 2013. 44 p.

BCG vaccination coverage among at-risk children followed by general practitioners in the Sentinelles Network, Inserm U707-InVS survey, metropolitan France, July–September 2009 (median age: 6 months).

%

95% CI

Ile-de-France

59

Outside Ile-de-France

32

Total

44

38–50

BCG vaccination coverage among at-risk children followed at maternal and child health centers in France, InVS survey, metropolitan France, April–June 2009

Age group

France (n=856)

Ile-de-France (n=481)

Outside Ile-de-France (n=375)

BCG coverage

95% CI

BCG CV

95% CI

BCG CV

95% CI

2–12 months

66.2%

59.1 – 72.7

86.7%

75.0–93.4

53.1%

44.6–61.5

12 months

83.0%

74.2 – 89.2

95.0%

86.3–98.3

75.5%

62.5–85.1

Total

72.6%

66.3–78.0

89.8%

81.4–94.7

61.7%

53.8–69.0

BCG vaccination coverage among at-risk children followed by private practitioners subscribed to the Infovac-France network, InVS-ACTIV survey, metropolitan France, February 2008 (%)

Ile-de-France

Outside Ile-de-France

Total

Children followed by physicians in exclusive or mixed private practice

Total

73

61

68

2–7 months

68

48

58

8–23 months

77

77

77

Children seen by physicians in private practice

Total

67

57

62

2–7 months

51

40

45

8–23 months

80

83

81

Children seen by physicians in mixed private practice

Total

78

65

73

2–7 months

82

58

71

8–23 months

75

73

74

24 months

BCG vaccination coverage at 24 months of age, France, 1995–2008 (Source: Drees, Data reported by maternal and child health services – 24-month health certificate. Processed by InVS)

1995(%)

1996(%)

1997(%)

1998(%)

1999(%)

2000(%)

2001(%)

2002(%)

2003(%)

2004(%)

2005(%)

2006(%)

2007(%)

2008(%)

82.7

81.7

81.8

81.1

82.6

83.1

83.9

84.5

84.2

85.1

81.2

83.3

78.2

44*
* The significant decline in 2008 corresponds to the discontinuation of the multi-puncture BCG vaccine in January 2006, but the large number of missing data points in 2008 requires a cautious interpretation of this figure. Except in the Île-de-France region (and French Guiana), data from 2009 onward are uninterpretable due to the absence of information in the health certificate indicating whether the child belongs to the target population for the vaccination recommendation. National analysis of BCG data from the 24-month health certificates will therefore only be possible after the new certificates have been distributed throughout France.

6 years

BCG vaccination coverage among children in the final year of preschool (ages 5–6), France (Source: Drees-Dgesco, national health surveys of children in the final year of preschool. Processed by InVS)

2002–2003

2005–2006

2012–2013

99.9%

96.5%

Not interpretable*
* In this survey, 48% of the children surveyed were born in 2007 before the mandatory vaccination requirement was lifted in July 2007, and 52% after that date. The latter group, for whom vaccination is recommended only in specific cases, could not be identified in the 2012–2013 survey due to the absence of this information in the questionnaire. These data do not allow for an estimate of national vaccination coverage in the target population.

11 years

BCG vaccination coverage among children in the fifth grade (CM2) (age 11), France (Source: Drees-Dgesco, national health surveys 2001–2002, 2004–2005, 2007–2008, and 2014–2015 among students in the final year of kindergarten. Analysis by Santé publique France)

2001-2002

2004-2005

2007–2008

2014-2015

99.5%

98.1% (95% CI: 97.6–98.5)

97.7% (95% CI: 97.3–98.1)

89.9% (95% CI: 88.6–91.0)

15 years

BCG vaccination coverage among 15-year-old students in 9th grade, France (Source: Drees-Dgesco, 2003–2004 and 2008–2009 national health surveys of 9th-grade students. Processed by InVS)

2003–2004

2008-2009

99.8%

98.4%